Compound Detail
CHEMBL4540502
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4540502 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WOVFSYAJXQSJES-BFJIOXTGSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
404.6
MW (Da)
4.71
ALogP
5
HBA
2
HBD
71.5
PSA (Ų)
0.39
QED
0
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 9.8
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| PANC-1 | IC50 | = | 0.16 | nM | 9.8 | Cytotoxicity against human PANC1 cells assessed as reduction in cell viability i... | 32071675 |
| HepG2 | IC50 | = | 0.27 | nM | 9.57 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i... | 32071675 |
| HCT-116 | IC50 | = | 0.35 | nM | 9.46 | Cytotoxicity against human HCT116 cells assessed as reduction in cell viability ... | 32071675 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32071675 | 10.1021/acsmedchemlett.9b00302 | No relevant target | 12 |
| 32071675 | 10.1021/acsmedchemlett.9b00302 | PANC-1 | 1 |
| 32071675 | 10.1021/acsmedchemlett.9b00302 | HepG2 | 1 |
| 32071675 | 10.1021/acsmedchemlett.9b00302 | HCT-116 | 1 |
Data from ChEMBL 36 via Core Engine